IBC Regulations
The regulations and principles that guide the IBC:
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines). These guidelines detail safety practices and containment procedures for basic and clinical research involving recombinant or synthetic nucleic acid molecules, including the creation and use of organisms and viruses containing recombinant or synthetic nucleic acid molecules.
- The Office of Biotechnology Activities (OBA). The NIH Office of Biotechnology Activities (OBA) promotes science, safety, and ethics in biotechnology through advancement of knowledge, enhancement of public understanding, and development of sound public policies (NIH Biosafety, Biosecurity, and Emerging Biotechnology). The OBA accomplishes its mission through analysis, deliberation, and communication of scientific, medical, ethical, legal, and social issues.
- Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition. The BMBL has become the code of practice for biosafety—the discipline addressing the safe handling and containment of infectious microorganisms and hazardous biological materials.
- Select Agents Regulations at 42 CFR 73 and 9 CFR 121. The Federal Select Agent Program is jointly comprised of the Centers for Disease Control, Prevention/Division of Select Agents and Toxins, and the Animal and Plant Health Inspection Service/Agriculture Select Agent Services. The Federal Select Agent Program oversees the possession, use and transfer of biological select agents and toxins, which have the potential to pose a severe threat to public, animal or plant health or to animal or plant products.
- Agricultural Select Agent Program (USDA). APHIS issues permits for the import, transit and release of regulated animals, animal products, veterinary biologics, plants, plant products, pests, organisms, soil, and genetically engineered organisms.
IBC Policies and Procedures
15.99.06.C1 Use of Biohazards in Research, Teaching, and Testing